News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cancelled Merck & Co., Inc. (MRK) Vaccine May Have Boosted HIV Risk


11/8/2007 12:50:22 AM

Evidence is building that an experimental AIDS vaccine given to 1,500 volunteers not only failed to protect those who received it, but may have put some of them at higher risk of contracting HIV than those who were given a placebo. At a Seattle meeting held Wednesday to discuss the latest findings, vaccine experts wrestled with the complex questions raised by the disappointing early results of the study, first disclosed by drugmaker Merck & Co. nearly seven weeks ago. Enrollment in the study was halted at the time, but researchers are still tracking the HIV status of the participants.

Read at Reuters
Read at Wall Street Journal
Read at Bloomberg
Read at ScienceDaily
Read at Reuters
Read at SF Gate

comments powered by Disqus
   
HIV/AIDS
Vaccine

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES